Patents | Intellepedia

After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.

Latest Patent Cases in 2021 – Part 1

The H. Lundbeck A/S vs Symed Labs Limited case involved a pre-notice settlement of a patent dispute, with the Delhi High Court decreeing the suit on agreed terms. The settlement clarifies the scope of Section 107A use and sets compliance and reporting obligations for the defendant.

Free Session on Patent Licensing and Commercialization by BananaIP and K-Tech CoE Data Science & AI – NASSCOM

The concluding session of the Intellectual Property MasterClass will address patent licensing and commercialization, with a focus on practical and legal aspects for businesses. Led by experienced professionals, this free session provides valuable insights for startups, SMEs, and innovators.

Free Masterclass on IP; Nokia and Daimler settle SEP patent dispute; EU submits alternative proposal to WTO against IP waiver and more

This week’s patent news features a free masterclass on patent filing, Nokia and Daimler’s settlement of a SEP dispute, and the EU’s alternative proposal to the WTO on IP waivers. Also covered are updates on the USPTO’s move to structured text filing for patent applications.

Upcoming: Free Webinar on Patent Process and Strategy – Session 3 of the Master Class on IP by BananaIP and NASSCOM’s KTech CoE on Data Science

Join the third session of the Certificate Master Class on IP to learn about the patent process in India and strategic patent management. The webinar includes presentations from leading patent attorneys and a demonstration of BananaIP’s free AI-based patent drafting tool.

Searching for Patents and Patentability of AI and Software Inventions: Session 2 of the Masterclass on IP

This session of the masterclass explored patentability criteria and search strategies for AI and software inventions. Attendees learned about the patent process, prior art search, and practical considerations for Indian innovators. The session offered valuable guidance on intellectual property for startups.

Dr. Kalyan C. Kankanala delivers a session on Patent Licensing to students at National Law School of India University, Bangalore

[slideshare id=249346522&doc=patentlicensing-210614051209]

Updated Patent, Trade Mark, Copyright and other Acts

The post offers updated and amended versions of major Indian intellectual property statutes following the abolition of the IPAB. Downloadable resources and detailed amendment summaries are provided for reference.

In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis for compulsory licensing and argues for its strategic use to ensure public access to vaccines and medicines.

Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

Natco Pharma has withdrawn its compulsory license application for Baricitinib following an agreement with Eli Lilly. The Indian Patent Office has extended procedural deadlines, and other significant updates in IP law are discussed, including ongoing litigation and international proposals.